A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients

A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients

Abstract Mortality of patients hospitalized with COVID-19 has remained high during the consecutive SARS-CoV-2 pandemic waves. Early discrimination of patients at high mortality risk is crucial for optimal patient care. Symmetric (SDMA) and asymmetric dimethylarginine (ADMA) have been proposed as pos...

Full description

Saved in:
Bibliographic Details
Main Authors: Juliane Hannemann, Anne Zink, Yoana Mileva, Paul Balfanz, Edgar Dahl, Sonja Volland, Thomas Illig, Edzard Schwedhelm, Florian Kurth, Alexandra Stege, Martin Aepfelbacher, Armin Hoffmann, Rainer Böger
Format: Article
Language:English
Published: Nature Portfolio 2024-07-01
Series:Scientific Reports
Subjects:
Infectious diseases
Nitric oxide
Intensive care
Biomarker
Online Access:https://doi.org/10.1038/s41598-024-66288-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-66288-3

Similar Items